Haematological Biomarkers Of Pathological Response On Neo-Adjuvant Chemo-Immunotherapy Treatment For Resectable Stage Iiia Non-Small Cell Lung Cancer (Nsclc) Patients.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 23|浏览63
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要